{
  "event_id": "499df3669d2b",
  "ticker": "BIIB",
  "company_name": "Biogen",
  "drug_name": "LEQEMBI lecanemab",
  "result": "approved",
  "pdufa_date": "2025-08-21",
  "approval_type": {
    "status": "found",
    "value": "bla",
    "source": "websearch:CLARITY AD Phase 3, NEJM 2023",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.193264",
    "error": null
  },
  "indication": {
    "status": "found",
    "value": "Early Alzheimer's Disease",
    "source": "websearch:CLARITY AD Phase 3, NEJM 2023",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.193265",
    "error": null
  },
  "generic_name": {
    "status": "found",
    "value": "lecanemab",
    "source": "websearch_fda",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:34:43.330127",
    "error": null
  },
  "therapeutic_area": {
    "status": "found",
    "value": "Neurology",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T10:49:58.558558",
    "error": null
  },
  "mechanism_of_action": {
    "status": "found",
    "value": "Anti-amyloid antibody",
    "source": "legacy_migration",
    "confidence": 0.75,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": "2026-01-10T12:42:32.139352",
    "error": null,
    "note": null
  },
  "phase": {
    "status": "found",
    "value": "Approved",
    "source": "websearch_clinical",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:34:43.330127",
    "error": null
  },
  "primary_endpoint_met": {
    "status": "found",
    "value": true,
    "source": "websearch:CLARITY AD Phase 3, NEJM 2023",
    "confidence": 0.95,
    "evidence": [
      "CLARITY AD Phase 3, NEJM 2023"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.193251",
    "error": null
  },
  "p_value": {
    "status": "found",
    "value": "0.00005",
    "source": "websearch:CLARITY AD Phase 3, NEJM 2023",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.193258",
    "error": null
  },
  "effect_size": {
    "status": "found",
    "value": "27% slowing of decline (CDR-SB -0.45)",
    "source": "websearch:CLARITY AD Phase 3, NEJM 2023",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.193260",
    "error": null
  },
  "has_prior_crl": {
    "status": "found",
    "value": false,
    "source": "derived_from_first_submission",
    "confidence": 0.95,
    "tier": 2
  },
  "is_resubmission": {
    "status": "found",
    "value": 0,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "pai_passed": {
    "status": "found",
    "value": true,
    "source": "derived_from_approval",
    "confidence": 0.95,
    "tier": 1,
    "note": "Approved drugs must have passed PAI"
  },
  "warning_letter": {
    "status": "found",
    "value": false,
    "source": "inferred_from_approval",
    "confidence": 0.8,
    "tier": 2,
    "note": "Approved drugs unlikely to have blocking warning letters"
  },
  "safety_signal": {
    "status": "found",
    "value": true,
    "source": "known_safety_database",
    "confidence": 0.95,
    "tier": 1,
    "reason": "ARIA risk",
    "severity": "medium"
  },
  "p_value_numeric": 5e-05,
  "nct_ids": [
    "NCT03887455",
    "NCT04468659"
  ],
  "phase3_study_names": [
    "A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease",
    "AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study With an Extension Phase to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer's Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer's Disease and Intermediate Amyloid (A3 Trial)"
  ],
  "prior_crl_reason": null,
  "enrollment": {
    "value": 1906,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2
  },
  "fda_designations": {
    "breakthrough_therapy": true,
    "fast_track": true,
    "priority_review": true,
    "orphan_drug": false,
    "accelerated_approval": true
  },
  "adcom_info": {
    "scheduled": true,
    "held": true,
    "date": null,
    "outcome": "favorable",
    "vote_for": null,
    "vote_against": null
  },
  "is_single_arm": {
    "value": false,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "interventionModel=PARALLEL",
      "allocation=RANDOMIZED"
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-11T08:29:40.170349",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "trial_region": {
    "value": "global",
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "countries=['SPAIN', 'UNITED KINGDOM', 'SOUTH KOREA', 'JAPAN', 'SWEDEN']..."
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-11T08:29:40.170405",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_biosimilar": {
    "value": false,
    "status": "found",
    "source": "originator_keyword_match",
    "confidence": 0.9,
    "tier": 2,
    "evidence": [
      "contains originator keyword: leqembi"
    ],
    "searched_sources": [
      "known_db",
      "patterns",
      "suffix_pattern",
      "approval_type"
    ],
    "last_searched": "2026-01-10T23:29:31.295935",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_first_in_class": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "crl_reason_type": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "warning_letter_date": {
    "value": null,
    "status": "confirmed_none",
    "source": "websearch_fda",
    "confidence": 0.8,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch_fda"
    ],
    "last_searched": "2026-01-11T04:05:14.852527",
    "error": null,
    "note": "No manufacturing warning letters found 2023-2025"
  },
  "fda_483_date": {
    "value": "2022-11-01",
    "status": "found",
    "source": "news",
    "confidence": 0.8,
    "tier": 3,
    "evidence": [
      "Facility: RTP, NC",
      "Outcome: N/A"
    ],
    "searched_sources": [
      "news"
    ],
    "last_searched": "2026-01-11T05:25:26.303247",
    "error": null,
    "facility": "RTP, NC"
  },
  "fda_483_observations": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "cdmo_name": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "pai_date": {
    "value": null,
    "status": "not_found",
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T13:34:28.104048",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": true,
    "is_complete": false
  },
  "clinical_hold_history": {
    "value": null,
    "status": "confirmed_none",
    "source": "websearch_clinical_hold",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch_clinical_hold"
    ],
    "last_searched": "2026-01-10T13:34:27.154526",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": false,
    "is_complete": true
  },
  "days_to_pdufa": -142,
  "pdufa_status": "past",
  "risk_tier": "HIGH",
  "days_calculated_at": "2026-01-10T16:59:38.073352",
  "original_case_id": "600fa2331963",
  "data_quality_score": 0.075,
  "collected_at": "2026-01-09T00:27:51.967426",
  "enriched_at": "2026-01-11T17:58:35.606319",
  "needs_manual_review": false,
  "review_reasons": [],
  "migrated_at": "2026-01-10T12:42:32.139375",
  "schema_version": "3.0",
  "adcom_scheduled": {
    "value": true,
    "status": "found",
    "source": "websearch_adcom",
    "confidence": 0.75,
    "tier": 3,
    "evidence": [
      "FDA panel gives unanimous support to Leqembi | pharmaphorum",
      "FDA Advisory Committee Confirms Efficacy of Leqembi",
      "FDA Advisory Committee Confirms Benefits of Leqembi to Treat ..."
    ],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:24:03.770722"
  },
  "adcom_vote_ratio": {
    "value": null,
    "status": "not_found",
    "source": "websearch_adcom",
    "confidence": 0.6,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:24:03.770731"
  },
  "breakthrough_therapy": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Lecanemab - Wikipedia"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:58:26.064244",
    "search_status": "FOUND"
  },
  "priority_review": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "FDA Advisory Committee Votes Unanimously to Confirm the ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:58:33.325027",
    "search_status": "FOUND"
  },
  "fast_track": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Eisai Completes Rolling Biologics License Application to FDA ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:58:34.512249",
    "search_status": "FOUND"
  },
  "orphan_drug": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:58:32.343627",
    "search_status": "CONFIRMED_NONE"
  },
  "accelerated_approval": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "FDA Grants Accelerated Approval for Alzheimerâ€™s Disease ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:58:35.606306",
    "search_status": "FOUND"
  }
}